Get the app
US › Healthcare

Scisparc Ltd (SPRC)

US · Healthcare · Biotechnology

$1.70-15.00%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$284,000
Revenue YoY
-66.2%
Net profit
$-5.4M
Net margin
-1,891.2%

Key statistics

Market cap
$46.1M
P/E
0.0
Forward P/E
0.0
P/B
0.69
Book value
$6.79
EPS (TTM)
$248.24
52-week high
$40.41
52-week low
$1.60
50-day MA
$5.49
200-day MA
$6.27
Beta
2.55

Shareholding

Institutions
9.25%

Largest institutional holders

FundStake
HRT FINANCIAL LLC3.66%
Jane Street Group LLC2.84%
Citadel Advisors Llc1.90%
UBS Group AG0.78%
JPMorgan Chase & Co0.04%
Royal Bank of Canada0.01%
SBI Securities Co Ltd0.00%
SRS Capital Advisors Inc0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Scisparc Ltd — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.